<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">An effective therapeutic approach for oxaliplatin-induced peripheral neuropathy using a combination therapy with goshajinkigan and bushi</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Informa UK Limited</publisher>
				<availability status="unknown"><p>Copyright Informa UK Limited</p>
				</availability>
				<date type="published" when="2016-07-14">2016-07-14</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keita</forename><surname>Mizuno</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Tsumura Research Laboratories</orgName>
								<orgName type="institution" key="instit2">Kampo Scientific Strategies Division</orgName>
								<orgName type="institution" key="instit3">Tsumura &amp; Co</orgName>
								<address>
									<addrLine>Ami-machi, Inashiki-gun</addrLine>
									<settlement>Yoshiwara, Ibaraki</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keisuke</forename><surname>Shibata</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Neuropharmacology</orgName>
								<orgName type="department" key="dep2">Interdisciplinary Graduate School of Medicine</orgName>
								<orgName type="institution">University of Yamanashi</orgName>
								<address>
									<settlement>Shimokato</settlement>
									<region>Chuo, Yamanashi</region>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ryohei</forename><surname>Komatsu</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Neuropharmacology</orgName>
								<orgName type="department" key="dep2">Interdisciplinary Graduate School of Medicine</orgName>
								<orgName type="institution">University of Yamanashi</orgName>
								<address>
									<settlement>Shimokato</settlement>
									<region>Chuo, Yamanashi</region>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuji</forename><surname>Omiya</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Tsumura Research Laboratories</orgName>
								<orgName type="institution" key="instit2">Kampo Scientific Strategies Division</orgName>
								<orgName type="institution" key="instit3">Tsumura &amp; Co</orgName>
								<address>
									<addrLine>Ami-machi, Inashiki-gun</addrLine>
									<settlement>Yoshiwara, Ibaraki</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshio</forename><surname>Kase</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Tsumura Research Laboratories</orgName>
								<orgName type="institution" key="instit2">Kampo Scientific Strategies Division</orgName>
								<orgName type="institution" key="instit3">Tsumura &amp; Co</orgName>
								<address>
									<addrLine>Ami-machi, Inashiki-gun</addrLine>
									<settlement>Yoshiwara, Ibaraki</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Schuichi</forename><surname>Koizumi</surname></persName>
							<email>skoizumi@yamanashi.ac.jp</email>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Neuropharmacology</orgName>
								<orgName type="department" key="dep2">Interdisciplinary Graduate School of Medicine</orgName>
								<orgName type="institution">University of Yamanashi</orgName>
								<address>
									<settlement>Shimokato</settlement>
									<region>Chuo, Yamanashi</region>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Department of Neuropharmacology, Interdisciplinary Graduate School of Medicine</orgName>
								<orgName type="institution">University of Yamanashi</orgName>
								<address>
									<addrLine>1110 Shimokato, Chuo, Yamanashi 409</addrLine>
									<postCode>3898</postCode>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">An effective therapeutic approach for oxaliplatin-induced peripheral neuropathy using a combination therapy with goshajinkigan and bushi</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Cancer Biology &amp; Therapy</title>
						<title level="j" type="abbrev">Cancer Biology &amp; Therapy</title>
						<idno type="ISSN">1538-4047</idno>
						<idno type="eISSN">1555-8576</idno>
						<imprint>
							<publisher>Informa UK Limited</publisher>
							<biblScope unit="volume">17</biblScope>
							<biblScope unit="issue">11</biblScope>
							<biblScope unit="page" from="1206" to="1212"/>
							<date type="published" when="2016-07-14" />
						</imprint>
					</monogr>
					<idno type="DOI">10.1080/15384047.2016.1210742</idno>
					<idno type="PMID">27416484</idno>
					<idno type="PMCID">PMC5137495</idno>
					<ptr type="open-access" target="https://www.tandfonline.com/doi/pdf/10.1080/15384047.2016.1210742?needAccess=true" />
					<note type="submission">Received 25 April 2016 Revised 3 June 2016 Accepted 3 July 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T23:15+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>CPT, Current perception threshold</term>
					<term>GJG, Goshajinkigan</term>
					<term>OIPN, Oxaliplatin-induced peripheral neuropathy</term>
					<term>TRP channels, Transient receptor potential channels Analgesic effect</term>
					<term>bushi</term>
					<term>combination therapy</term>
					<term>goshajinkigan</term>
					<term>oxaliplatin</term>
					<term>peripheral neuropathy</term>
					<term>traditional Japanese medicine</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Oxaliplatin-induced peripheral neuropathy (OIPN) occurs at extraordinarily high frequency, but no effective treatment for this disorder has been established. Goshajinkigan (GJG), a traditional Japanese medicine known as Kampo, is known to reduce OIPN in both basic and clinical studies. However, its molecular mechanisms remain largely unknown. Here, we elucidate the mechanisms underlying the therapeutic effects of GJG against OIPN and the therapeutic benefits of combining GJG with bushi, a herbal medicine derived from the processed Aconiti tuber. Oxaliplatin (4 mg/kg) was injected into mice twice a week for up to 4 and 3 weeks, respectively. OIPN was assessed using pain behavioral tests, such as those testing cold hypersensitivity, thermal hyperalgesia, and mechanical allodynia, as well as a reduction of the current perception threshold (CPT). GJG (0.3 or 1 g/kg) and bushi (0.1 or 0.3 g/kg) were orally administered 5 times a week for 4 weeks. Behavioral analysis was performed 24 h after the final dose. Oxaliplatin induced cold hypersensitivity and mechanical allodynia but not thermal hyperalgesia and reduced CPT of Ad-and Ab-fibers but not C-fibers. All these effects were counteracted by GJG. Bushi, an ingredient of GJG that shows analgesic effect, reduced oxaliplatin-induced cold hypersensitivity but had no effect on oxaliplatininduced mechanical allodynia. However, bushi significantly accentuated the effects of GJG when coadministered with GJG. GJG reduces OIPN by counteracting the sensitization of Ad-and Ab-fibers and shows analgesic effects against cold hypersensitivity and mechanical allodynia. These effects are potentiated by bushi. The combination of GJG with bushi has high potential for preventing OIPN.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Oxaliplatin, a third-generation platinum drug, is widely used to treat advanced/recurrent colorectal cancer. <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref> Oxaliplatin causes neuropathy as an adverse effect with an extraordinarily high frequency, which is viewed with suspicion because it is the most common dose-limiting factor for oxaliplatin therapy. <ref type="bibr" target="#b4">[4]</ref><ref type="bibr" target="#b5">[5]</ref><ref type="bibr" target="#b7">[6]</ref> The acute phase of oxaliplatin-induced peripheral neuropathy (OIPN) is characterized by cold hypersensitivity, which is followed by the chronic phase of OIPN characterized by sensory ataxia, numbness, and sensations of pain, such as mechanical allodynia. These symptoms of OIPN worsen with continued oxaliplatin therapy; therefore, the discontinuation of oxaliplatin therapy is frequently required, leading to a decrease in therapeutic effects. However, a limited number of OIPN treatments, such as calcium gluconate and magnesium sulfate, <ref type="bibr" target="#b8">7</ref> analgesic drugs (pregabalin and opioids) <ref type="bibr" target="#b9">8,</ref><ref type="bibr" target="#b11">9</ref> and antioxidants (silibinin and polyphenols, such as quercetin), <ref type="bibr" target="#b13">10,</ref><ref type="bibr" target="#b14">11</ref> have been investigated in basic and clinical research, and they have not achieved satisfactory outcomes in clinical practice.</p><p>Goshajinkigan (GJG), a traditional Japanese herbal medicine known as Kampo, has been widely used in Japan to treat rhigosis or numbness in the extremities and disease-associated neuropathies, such as diabetic neuropathy. <ref type="bibr" target="#b16">12,</ref><ref type="bibr" target="#b17">13</ref> Recent accumulating evidences in basic and clinical studies indicate that GJG improves OIPN. <ref type="bibr" target="#b18">[14]</ref><ref type="bibr" target="#b19">[15]</ref><ref type="bibr" target="#b21">[16]</ref><ref type="bibr" target="#b22">[17]</ref> Mizuno et al recently demonstrated in an acute OIPN rat model that GJG prevents oxaliplatin-induced cold hypersensitivity by suppressing cold-sensitive TRP channels, such as TRPA1 and TRPM8, in peripheral sensory neurons. <ref type="bibr" target="#b23">18</ref> However, the mechanisms underlying the GJG-induced amelioration of OIPN, especially the cumulative neuropathy, remain unknown.</p><p>Bushi (TJ-3023, Tsumura &amp; Co., Japan), a herbal medicine derived from the processed Aconiti tuber, is one of the ingredients of GJG and is well known to show an analgesic effect; <ref type="bibr" target="#b24">19,</ref><ref type="bibr" target="#b25">20</ref> thus, it is used not only for chronic and persistent pain, including neuropathic pain, but also to potentiate the analgesic effects of some kinds of Kampo medicines in Japan. <ref type="bibr" target="#b27">21</ref> Thus, bushi might potentiate the analgesic effects of GJG in OIPN when co-administered.</p><p>In the present study, we demonstrate that OIPN, manifested as cold hypersensitivity and mechanical allodynia, is associated with the sensitization of Ad-and Ab-fibers, which is inhibited by GJG in a mouse model. In addition, we demonstrate that GJG, when combined with bushi, dramatically increases analgesic effects, demonstrating that a combination therapy using GJG and bushi is a potential strategy for OIPN treatment.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>GJG inhibits oxaliplatin-induced cold hypersensitivity and mechanical allodynia but not thermal hyperalgesia in mice</head><p>The repeated injection of oxaliplatin (4 mg/kg) induced a sustained cold allodynia, measured as an increase in the duration of withdrawal responses to cold stimulation using the acetone test, in mice from day 3 after the first injection ( <ref type="figure">Fig. 1A)</ref>. Oxaliplatin also led to a persistent cold hyperalgesia, measured as a decrease in the latency of withdrawal responses using the cold plate test, from day 3 after the first injection ( <ref type="figure">Fig. 1B)</ref>. GJG (1 g/kg) ameliorated the oxaliplatin-induced cold hypersensitivity at all the time points tested ( <ref type="figure">Fig. 1A and B</ref>). GJG ameliorated the cold allodynia in a concentration-dependent manner over a concentration range from 0.3 to 1 g/kg <ref type="figure">(Fig. 1E</ref>). However, oxaliplatin never induced thermal hyperalgesia, measured as a decrease in the latency of withdrawal <ref type="figure">Figure 1</ref>. Goshajinkigan inhibits oxaliplatin-induced cold hypersensitivity and mechanical allodynia but not thermal hyperalgesia in mice. Oxaliplatin (4 mg/kg) was injected intraperitoneally twice a week for 4 weeks. Goshajinkigan (GJG) (0.3 or 1 g/kg) was administered orally, immediately after the injection of oxaliplatin, 5 times a week for 4 weeks. The acetone test was performed at the indicated periods (A) and on day 3 (E) to assess the effects of GJG on oxaliplatin-induced cold allodynia. The cold plate (B) and hot plate (C) tests were performed at the indicated periods. The latency of the withdrawal response against each thermal stimulus was measured. The von Frey test was performed to assess mechanical allodynia at the indicated periods (D) and on day 18 (F). The paw withdrawal response to the tactile stimulus was evaluated. d; days after oxaliplatin treatment; ÃÃ P &lt; 0.01 compared with the control group; # P &lt; 0.05, ## P &lt; 0.01 compared with the oxaliplatin-treated group. Data are expressed as the mean § standard error of the mean. n D 5-6 per group. responses using the hot plate test <ref type="figure">(Fig. 1C</ref>). As shown in <ref type="figure">Fig. 1D</ref>, oxaliplatin also caused mechanical allodynia, which had a slow onset and was significantly increased at day 11 and later after the first administration of oxaliplatin. GJG (1 g/kg) significantly inhibited the oxaliplatin-induced mechanical allodynia, but the lower dose of GJG (0.3 g/kg) had no effect <ref type="figure">(Fig. 1F</ref>).</p><p>The oxaliplatin-induced hyperactivation of Ad-and Ab-fibers, and its inhibition by GJG</p><p>The repeated injection of oxaliplatin had no effect on the threshold of the 5-Hz stimulus, which is a measure of the sensitivity of C-fibers ( <ref type="figure" target="#fig_0">Fig. 2A and B</ref>). However, oxaliplatin significantly reduced the threshold of withdrawal responses to the 250-and 2000-Hz stimuli at day 12 and day 5, respectively, which lasted at least until day 26 ( <ref type="figure" target="#fig_0">Fig. 2C</ref> and E). Thus, oxaliplatin increased the sensitivities of Ad-and Ab-fibers but not C-fibers. GJG (1 g/kg) significantly ameliorated these changes in sensitivity at all time points ( <ref type="figure" target="#fig_0">Fig. 2C</ref> and E). The effects of GJG were not observed at the lower dose (0.3 g/kg) ( <ref type="figure" target="#fig_0">Fig. 2D and F)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Bushi potentiated the ameliorating effects of GJG against OIPN</head><p>Bushi itself has analgesic effects; in fact, bushi (0.3 g/kg) alone reduced oxaliplatin-induced cold allodynia <ref type="figure">(Fig. 3A)</ref>. When coadministered with GJG (0.3 g/kg), bushi significantly enhanced the anti-cold allodynic effects of GJG <ref type="figure">(Fig. 3C)</ref>. In contrast, neither bushi (0.3 g/kg) alone nor GJG (0.3 g/kg) alone showed an analgesic effect against mechanical allodynia. However, when they were co-administered, they significantly inhibited oxaliplatin-induced mechanical allodynia ( <ref type="figure">Fig. 3B and D)</ref>. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>In this study, we demonstrated that OIPN is associated with the sensitization of Ad-and Ab-fibers, all of which were inhibited by GJG. Furthermore, we found that bushi, one of the ingredients of GJG that is thought to be important for the analgesic effects of GJG, significantly enhanced the therapeutic effects of GJG when used in combination with GJG. This suggests that a combination therapy using GJG and bushi is a potential strategy for OIPN treatment.</p><p>We initially characterized OIPN in mice and investigated the effects of GJG on OIPN. We found that oxaliplatin caused cold hypersensitivity in the early period ( <ref type="figure">Fig. 1A and B</ref>), which was followed by mechanical allodynia <ref type="figure">(Fig. 1D</ref>). Interestingly, it did not cause thermal hyperalgesia <ref type="figure">(Fig. 1C</ref>). These characteristics of neuropathy in mice were similar to those seen in the clinical symptoms in human. <ref type="bibr" target="#b4">4,</ref><ref type="bibr" target="#b7">6</ref> We also investigated the effects of oxaliplatin on the sensitivity of individual peripheral sensory neurons using a neurometer test <ref type="bibr" target="#b28">22</ref> and found that oxaliplatin causes a significant increase in the responsiveness of myelinated peripheral sensory neurons, including Ad-and Abfibers, which sense fast pain and tactile pressure, respectively. However, oxaliplatin did not affect C-fibers <ref type="figure" target="#fig_0">(Fig. 2)</ref>. The time course of sensitivity of these A-fibers was roughly the same as that of mechanical allodynia. Unlike nociceptive pain, mechanical allodynia starts with a sense of innocuous tactile stimuli by non-nociceptive neurons, such as Ab-fibers, which somehow transmit tactile stimuli as pain in pathological conditions. The sensitization of Ab-fibers, therefore, would be the most likely event responsible for oxaliplatin-induced mechanical allodynia. GJG significantly inhibited mechanical allodynia ( <ref type="figure">Fig. 1D and  F</ref>) and the sensitization of Ad-and Ab-fibers ( <ref type="figure" target="#fig_0">Fig. 2C-F)</ref>. In addition, Kono et al reported a morphological analysis demonstrated that oxaliplatin causes the atrophy of axons containing myelinated nerve fibers but not non-myelinated nerve fibers in the sciatic nerves in rats and that this effect was ameliorated by GJG. <ref type="bibr" target="#b22">17</ref> The simplest interpretation of these findings is that an increase in the sensitivity of either Ad-or Ab-fibers or both is involved in the induction of mechanical allodynia and that GJG, acting on these sensory fibers, inhibits their sensitization.</p><p>As for heat sensation, the main heat sensor TRPV1 is almost extensively located in C-fibers. <ref type="bibr" target="#b29">23</ref> This leads to the interpretation that oxaliplatin affects neither thermal hyperalgesia <ref type="figure">(Fig. 1C)</ref> nor the sensitivity of C-fibers ( <ref type="figure" target="#fig_0">Fig. 2A and B)</ref>. As for cold <ref type="figure">Figure 3</ref>. Bushi potentiates the ameliorating effects of goshajinkigan against oxaliplatin-induced peripheral neuropathy. Goshajinkigan (GJG) (0.3 g/kg) and/or bushi (0.1 or 0.3 g/kg) were administered orally, immediately after the injection of oxaliplatin, 5 times a week for 3 weeks. The acetone test was performed on day 3 ((A)and C). The von Frey test was performed on day 18 ((B) and D). ÃÃ P &lt; 0.01 compared with the control group; # P &lt; 0.05, ## P &lt; 0.01 compared with the oxaliplatin-treated group. $ P &lt; 0.05, $$ P &lt; 0.01 compared with the oxaliplatin C GJG group. Data are expressed as the mean § standard error of the mean. n D 10 per group. sensation, the cold sensors TRPA1 and TRPM8 are functionally upregulated in dorsal root ganglion neurons after treatment with oxaliplatin. <ref type="bibr" target="#b23">18,</ref><ref type="bibr" target="#b31">24,</ref><ref type="bibr" target="#b33">25</ref> TRPA1 is mainly colocalized with TRPV1-positive neurons, which are present in C-fibers, whereas TRPM8 is located in both C-and A-fibers. <ref type="bibr" target="#b29">23</ref> Oxaliplatin, however, induced cold hypersensitivity despite it having no effect on the sensitivity of C-fibers in our study. Thus, the simplest interpretation of our present results is that in our model or administration schedule, oxaliplatin mainly acted on and sensitized TRPM8 in myelinated A-fibers, thereby leading to cold hypersensitivity. Alternatively, oxaliplatin may upregulate TRPA1 or molecules other than TRPA1 in A-fibers or may affect TRPM8 in A-fibers. Although the mechanisms underlying oxaliplatin-induced cold hypersensitivity are still unknown, we demonstrated that GJG significantly inhibited cold hypersensitivity <ref type="figure">(Fig. 1A, B</ref> and E) and the sensitization of Ad-and Ab-fibers ( <ref type="figure" target="#fig_0">Fig. 2C-F)</ref>. Considering the present results that oxaliplatin sensitized only myelinated A-fibers, where TRPA1 is not present, <ref type="bibr" target="#b29">23</ref> GJG may mainly act on and inhibit TRPM8 in A-fibers and, thereby, inhibit cold hypersensitivities. However, further studies are needed to clarify this.</p><p>Another important finding is that bushi, one of the ingredients of GJG, significantly enhances the therapeutic effects of GJG, thus proposing a combination therapy using GJG and bushi. Bushi is widely used in Japan for several types of chronic and persistent pains, including neuropathic pain. It has been shown to potentiate the analgesic effects of some kinds of Kampo medicine. <ref type="bibr" target="#b27">21</ref> Bushi, at a dose of 0.3 g/kg, improved cold allodynia <ref type="figure">(Fig. 3A)</ref> and significantly potentiated the effects of GJG against it <ref type="figure">(Fig. 3C)</ref>. These results suggest that bushi may play a pivotal role in the ameliorating effects of GJG against cold allodynia and that a combination of GJG and bushi may contribute to potentiating the action against it. However, a further study to examine the effect of GJG eliminating bushi on cold allodynia is needed to clarify whether bushi is the active ingredient of GJG against it. Interestingly, neither GJG alone nor bushi alone at a dose of 0.3 g/kg inhibited the oxaliplatininduced mechanical allodynia <ref type="figure">(Fig. 3B</ref>), but when co-administered, they significantly inhibited mechanical allodynia <ref type="figure">(Fig. 3D)</ref>. Although the mechanisms underlying mechanical allodynia are not simple, allodynia includes both peripheral and central neuronal phenomena. As for central mechanisms, the activation of spinal microglia <ref type="bibr" target="#b34">26</ref> or astrocytes <ref type="bibr" target="#b25">20</ref> is known to be highly related to the pathogenesis of neuropathic pain. It has become apparent that glial cells, especially microglia and astrocytes, in the spinal cord play a substantial role in the pathogenesis of neuropathy induced by anti-cancer agents, such as paclitaxel, vincristine, and oxaliplatin. <ref type="bibr" target="#b36">[27]</ref><ref type="bibr" target="#b37">[28]</ref><ref type="bibr" target="#b39">[29]</ref> Furthermore, we found that bushi is a strong inhibitor of astrocytic activation and revealed its anti-allodynic effect caused by inhibiting spinal astrocytes in the Seltzer mouse model. <ref type="bibr" target="#b25">20</ref> However, in the present study, the activation of glial cells (changes in the localization and morphology of microglia and astrocytes) was not observed in the spinal dorsal horn of oxaliplatin-treated mice on days 5 and 19 using immunohistochemical analyses (data not shown). The reason for the failure of bushi alone to inhibit the oxaliplatin-induced mechanical allodynia is either because spinal astrocytes, the target cells of bushi, were not activated in our OIPN model or because the symptom types of OIPN are not exactly the same as those of neuropathic pain. Bushi has a variety of other pharmacological activities, including a thermal effect, an increase in blood flow, and the inhibition of platelet aggregation, <ref type="bibr" target="#b40">[30]</ref><ref type="bibr" target="#b41">[31]</ref><ref type="bibr" target="#b42">[32]</ref> thus, we do not exclude the possibility that bushi may potentiate the therapeutic effects of GJG via these pharmacological activities.</p><p>In conclusion, we demonstrated that GJG prevented acute and cumulative neuropathy using an OIPN mouse model. Furthermore, we found that bushi potentiated the ameliorating effects of GJG against OIPN. Thus, the combination of GJG with bushi can improve the symptoms of patients who do not respond adequately to monotherapy with either GJG or bushi. These findings are expected to improve treatments and support future clinical trials associated with oxaliplatin therapy.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Animals</head><p>Eight-week-old male ICR mice (Japan SLC, Shizuoka, Japan) were used in the present study. They were kept under controlled temperature at 23 § 3 C and relative humidity of 50 § 20%, with a 12-h light/dark cycle. Animals were allowed free access to solid food and water in their home cages (4-5 mice per cage). All experimental procedures were performed according to the Guidelines for the Care and Use of Laboratory Animals approved by the Laboratory Animal Committee of Tsumura &amp; Co.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Drugs</head><p>Oxaliplatin was purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). GJG is composed of 10 herbal medicines: Rehmanniae radix (5.0 g), Achyranthis radix (3.0 g), Corni fructus (3.0 g), Moutan cortex (3.0 g), Alismatics rhizome (3.0 g), Dioscoreae rhizome (3.0 g), Plantaginis semen (3.0 g), Hoelen (3.0 g), processed Aconiti tuber (1.0 g), and Cinnamomi cortex (1.0 g). This drug was prepared as a spraydried powder from a hot-water extract (yield 16%) and obtained from Tsumura &amp; Co. (Tokyo). Bushi (TJ-3023), a processed Aconiti tuber, was also obtained from Tsumura &amp; Co. Oxaliplatin was dissolved in 5% glucose solution. GJG and bushi were dissolved in distilled water.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Experimental schedule</head><p>To establish an OIPN mouse model, oxaliplatin (4 mg/kg body weight) or its vehicle (5% glucose solution) was injected intraperitoneally twice a week for 4 weeks (days <ref type="bibr">1, 2, 8, 9, 15, 16, 22, and 23)</ref>. GJG (0.3 or 1 g/kg body weight) and bushi (0.1 or 0.3 g/kg body weight) were administered orally 5 times a week for up to 4 and 3 weeks, respectively. The acetone test and cold plate test, which are used to assess cold sensations, and the hot plate test, which is used to assess heat sensations, were performed on days 0, 3, 10, 17, and 24. The von Frey test, which is used to assess mechanical allodynia, was performed on days 0, 4, 11, 18, and 25. The neurometer test, which is used to assess the threshold of peripheral sensory neurons to electrical stimuli, was performed on days 0, 5, 12, 19, and 26.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Assessment of cold hyperalgesia and cold allodynia</head><p>Cold hyperalgesia induced by oxaliplatin was assessed using a cold plate test, which was performed according to the method described by Mizuno et al. <ref type="bibr" target="#b23">18</ref> Briefly, mice were placed on a Hot/ Cold Plate Analgesia Meter (MK-350HC, Muromachi Kikai Co., Ltd, Tokyo, Japan), the temperature of which was kept at 4 C. The latency of withdrawal responses, such as the elevation and licking of each hind paw, during 150 s were recorded. Cold allodynia induced by oxaliplatin was assessed using the acetone test. Approximately 50 ml acetone (Wako Pure Chemical Ltd., Osaka, Japan) was sprayed onto the plantar skin of the right hind paw, and the time spent in the elevation and licking of the stimulated hind paw during 60 s was measured.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Assessment of thermal hyperalgesia</head><p>The hot plate test was performed to assess thermal hyperalgesia. Mice were placed on a Hot/Cold Plate Analgesia Meter, the temperature of which was kept at 50 C. A cut-off time of 45 s was set to prevent tissue damage. The latency of withdrawal responses, such as the licking and flinching of each hind paw, was recorded.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Assessment of mechanical allodynia</head><p>The von Frey test, which was used to assess mechanical allodynia, was performed according to the method described by Shibata et al. <ref type="bibr" target="#b25">20</ref> Briefly, a 0.16 g von Frey filament was applied to the plantar surface of the right hind paw. The paw withdrawal in response to the tactile stimulus was scored as follows: 0, no response; 1, a withdrawal response away from the stimulus with slight flinching and/or licking; and 2, an intense withdrawal response away from the stimulus with brisk flinching and/or licking. One trial involved 10 applications of the filament, each of which was scored as 0, 1, or 2. The trial was evaluated based on a total score of 0-20 at the culmination of the test (% of maximum score).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measurement of current perception threshold</head><p>The neurometer test, which was used to assess the thresholds of peripheral sensory neurons, was performed according to the method described by Matsumoto et al. <ref type="bibr" target="#b28">22</ref> Briefly, electrodes (Neurotron Inc., Baltimore, MD) were attached to the right planter surfaces of the hind paw. Transcutaneous neuronal stimuli (sinewave pulses of 5, 250, or 2000 Hz for activation of the C-, Ad-, or Ab-fibers, respectively) were applied using a Neurometer Ò CPT Ò / C (Neurotron Inc.). The minimum intensity (mA) at which each mouse showed a withdrawal response of the stimulated hind paw was defined as the current threshold.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p>All results are expressed as the mean § standard error of the mean. All statistical analyses were performed using StatLight2000 software (Yukms Co., Ltd, Tokyo, Japan). All behavioral data, except for that of the von Frey test, were analyzed using one-way analysis of variance (ANOVA) with post hoc multiple comparison using Tukey's test. The data for the von Frey test were analyzed using ANOVA performed with Scheff e's multiple comparison tests. Differences resulting in P values of &lt;0.05 were considered statistically significant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure of potential confllicts of interest</head><p>No potential conflicts of interest were disclosed.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 2 .</head><label>2</label><figDesc>The oxaliplatin-induced hyperactivation of Ad-and Ab-fibers, and its inhibition by goshajinkigan. The sensitivities of different types of peripheral neurons (C-, Ad-, and Ab-fibers) were assessed using a neurometer test. The thresholds of paw withdrawal responses to electrical stimuli with 5 Hz (C-fibers, (A)and B), 250 Hz (Adfibers, (C)and D), and 2000 Hz (Ab-fibers, (E)and F) were measured. (A), (C), and (E) shows the time courses of sensitization of C-, Ad-, and Ab-fibers, respectively. (B), (D), and (F) show the concentration dependence of the effects of goshajinkigan on the sensitivity of C-, Ad-, and Ab-fibers, respectively on day 19. d, days after oxaliplatin treatment; Ã P &lt; 0.05, ÃÃ P &lt; 0.01 compared with the control group; ## P &lt; 0.01 compared with the oxaliplatin-treated group. Data are expressed as the mean § standard error of the mean. n D 5-6 per group.</figDesc></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">A</forename><surname>De</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Figer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Seymour</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Homerin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Hmissi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Cassidy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Boni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Cortes-Funes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Cervantes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Freyer</surname></persName>
		</author>
		<idno type="PMID">10944126</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="2938" to="2985" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: colon cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">F</forename><surname>Engstrom</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Arnoletti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Benson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Choti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">S</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Covey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Dilawari</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">S</forename><surname>Early</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Enzinger</surname></persName>
		</author>
		<idno type="PMID">19755046</idno>
	</analytic>
	<monogr>
		<title level="j">J Natl Compr Canc Netw</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="778" to="831" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Andr E</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Boni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Mounedji-Boudiaf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Navarro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Tabernero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Hickish</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Topham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Zanillnelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Clingan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Bridgewater</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">350</biblScope>
			<biblScope unit="page" from="2343" to="51" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thierry</forename><surname>André</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Corrado</forename><surname>Boni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lamia</forename><surname>Mounedji-Boudiaf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matilde</forename><surname>Navarro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Josep</forename><surname>Tabernero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tamas</forename><surname>Hickish</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Clare</forename><surname>Topham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marta</forename><surname>Zaninelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Philip</forename><surname>Clingan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><surname>Bridgewater</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Isabelle</forename><surname>Tabah-Fisch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aimery</forename><surname>De Gramont</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa032709</idno>
		<idno type="PMID">15175436</idno>
		<ptr type="open-access" target="http://diposit.ub.edu/dspace/bitstream/2445/126391/3/AndreT.pdf" />
		<ptr target="http://dx.doi.org/10.1056/NEJMoa032709" />
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<title level="j" type="abbrev">N Engl J Med</title>
		<idno type="ISSN">0028-4793</idno>
		<idno type="ISSNe">1533-4406</idno>
		<imprint>
			<biblScope unit="volume">350</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="2343" to="2351" />
			<date type="published" when="2004-06-03" />
			<publisher>New England Journal of Medicine (NEJM/MMS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Oxaliplatin-induced neurotoxicity: Acute hyperexcitability and chronic neuropathy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">J</forename><surname>Lehky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">D</forename><surname>Leonard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">H</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Grem</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">K</forename><surname>Floeter</surname></persName>
		</author>
		<idno type="DOI">10.1002/mus.10559</idno>
		<idno type="PMID">14981738</idno>
		<idno type="ark">ark:/67375/WNG-FS2Q8GBP-5</idno>
		<idno type="istexId">864BD8765A2A520C05DE3FCCA2EF2B92F22F7404</idno>
		<ptr target="http://dx.doi.org/10.1002/mus.10559" />
	</analytic>
	<monogr>
		<title level="j">Muscle &amp; Nerve</title>
		<title level="j" type="abbrev">Muscle Nerve</title>
		<idno type="ISSN">0148-639X</idno>
		<idno type="ISSNe">1097-4598</idno>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="387" to="392" />
			<date type="published" when="2004" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Oxaliplatin-related neurotoxicity: How and why?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lara</forename><forename type="middle">Maria</forename><surname>Pasetto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mario</forename><forename type="middle">Rosario</forename><surname>D’andrea</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elena</forename><surname>Rossi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Silvio</forename><surname>Monfardini</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.critrevonc.2006.01.001</idno>
		<idno type="PMID">16806962</idno>
	</analytic>
	<monogr>
		<title level="j">Critical Reviews in Oncology/Hematology</title>
		<title level="j" type="abbrev">Critical Reviews in Oncology/Hematology</title>
		<idno type="ISSN">1040-8428</idno>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="159" to="168" />
			<date type="published" when="2006-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Oxaliplatin-related neurotoxicity: How and why?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lara</forename><forename type="middle">Maria</forename><surname>Pasetto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mario</forename><forename type="middle">Rosario</forename><surname>D’andrea</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elena</forename><surname>Rossi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Silvio</forename><surname>Monfardini</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.critrevonc.2006.01.001</idno>
		<idno type="PMID">16806962</idno>
		<ptr target="http://dx.doi.org/10.1016/j.critrevonc.2006.01.001" />
	</analytic>
	<monogr>
		<title level="j">Critical Reviews in Oncology/Hematology</title>
		<title level="j" type="abbrev">Critical Reviews in Oncology/Hematology</title>
		<idno type="ISSN">1040-8428</idno>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="159" to="168" />
			<date type="published" when="2006-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Oxaliplatin-induced neurotoxicity and the development of neuropathy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Arun</forename><forename type="middle">V</forename><surname>Krishnan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Friedlander</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthew</forename><forename type="middle">C</forename><surname>Kiernan</surname></persName>
		</author>
		<idno type="DOI">10.1002/mus.20340</idno>
		<idno type="PMID">15880395</idno>
		<idno type="ark">ark:/67375/WNG-JQRCXB8K-C</idno>
		<idno type="istexId">E771D67400F46A142A78115AC316F47DA411B0C1</idno>
		<ptr target="http://dx.doi.org/10.1002/mus.20340" />
	</analytic>
	<monogr>
		<title level="j">Muscle &amp; Nerve</title>
		<title level="j" type="abbrev">Muscle Nerve</title>
		<idno type="ISSN">0148-639X</idno>
		<idno type="ISSNe">1097-4598</idno>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="51" to="60" />
			<date type="published" when="2005" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions: A Retrospective Study of 161 Patients Receiving Oxaliplatin Combined with 5-Fluorouracil and Leucovorin for Advanced Colorectal Cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Gamelin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Boisdron-Celle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Delva</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Gu Erin-Meyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Ifrah</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Morel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Gamelin</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.ccr-03-0666</idno>
		<idno type="PMID">15217938</idno>
		<ptr type="open-access" target="http://clincancerres.aacrjournals.org/content/10/12/4055.full.pdf" />
		<ptr target="http://dx.doi.org/10.1158/1078-0432.CCR-03-0666" />
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<title level="j" type="abbrev">Clinical Cancer Research</title>
		<idno type="ISSN">1078-0432</idno>
		<idno type="ISSNe">1557-3265</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="4055" to="4061" />
			<date type="published" when="2004-06-15" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Muhammad</forename><forename type="middle">Wasif</forename><surname>Saif</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shahrukh</forename><surname>Hashmi</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00280-007-0584-7</idno>
		<idno type="PMID">17849118</idno>
		<idno type="ark">ark:/67375/VQC-HMVK3XW0-1</idno>
		<idno type="istexId">6ECCBCBA78C21FCAA5EC0D7B5493E3C5AAD0A36D</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Chemotherapy and Pharmacology</title>
		<title level="j" type="abbrev">Cancer Chemother Pharmacol</title>
		<idno type="ISSN">0344-5704</idno>
		<idno type="ISSNe">1432-0843</idno>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="349" to="354" />
			<date type="published" when="2007-09-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Muhammad</forename><forename type="middle">Wasif</forename><surname>Saif</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shahrukh</forename><surname>Hashmi</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00280-007-0584-7</idno>
		<idno type="PMID">17849118</idno>
		<idno type="ark">ark:/67375/VQC-HMVK3XW0-1</idno>
		<idno type="istexId">6ECCBCBA78C21FCAA5EC0D7B5493E3C5AAD0A36D</idno>
		<ptr target="http://dx.doi.org/10.1007/s00280-007-0584-7" />
	</analytic>
	<monogr>
		<title level="j">Cancer Chemotherapy and Pharmacology</title>
		<title level="j" type="abbrev">Cancer Chemother Pharmacol</title>
		<idno type="ISSN">0344-5704</idno>
		<idno type="ISSNe">1432-0843</idno>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="349" to="354" />
			<date type="published" when="2007-09-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Establishment of Opioid-Induced Rewarding Effects Under Oxaliplatin- and Paclitaxel-Induced Neuropathy in Rats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomohisa</forename><surname>Mori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomoe</forename><surname>Kanbara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masato</forename><surname>Harumiya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshiyuki</forename><surname>Iwase</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aki</forename><surname>Masumoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sachiko</forename><surname>Komiya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Atsushi</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masahiro</forename><surname>Shibasaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toshiyuki</forename><surname>Kanemasa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gaku</forename><surname>Sakaguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tsutomu</forename><surname>Suzuki</surname></persName>
		</author>
		<idno type="DOI">10.1254/jphs.14134fp</idno>
		<idno type="PMID">25141998</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/jphs/126/1/126_14134FP/_pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Pharmacological Sciences</title>
		<title level="j" type="abbrev">J Pharmacol Sci</title>
		<idno type="ISSN">1347-8613</idno>
		<idno type="ISSNe">1347-8648</idno>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="47" to="55" />
			<date type="published" when="2014" />
			<publisher>Japanese Pharmacological Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Establishment of Opioid-Induced Rewarding Effects Under Oxaliplatin- and Paclitaxel-Induced Neuropathy in Rats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomohisa</forename><surname>Mori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomoe</forename><surname>Kanbara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masato</forename><surname>Harumiya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshiyuki</forename><surname>Iwase</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aki</forename><surname>Masumoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sachiko</forename><surname>Komiya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Atsushi</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masahiro</forename><surname>Shibasaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toshiyuki</forename><surname>Kanemasa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gaku</forename><surname>Sakaguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tsutomu</forename><surname>Suzuki</surname></persName>
		</author>
		<idno type="DOI">10.1254/jphs.14134fp</idno>
		<idno type="PMID">25141998</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/jphs/126/1/126_14134FP/_pdf" />
		<ptr target="http://dx.doi.org/10.1254/jphs.14134FP" />
	</analytic>
	<monogr>
		<title level="j">Journal of Pharmacological Sciences</title>
		<title level="j" type="abbrev">J Pharmacol Sci</title>
		<idno type="ISSN">1347-8613</idno>
		<idno type="ISSNe">1347-8648</idno>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="47" to="55" />
			<date type="published" when="2014" />
			<publisher>Japanese Pharmacological Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The Antioxidant Effects of the Flavonoids Rutin and Quercetin Inhibit Oxaliplatin-Induced Chronic Painful Peripheral Neuropathy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><forename type="middle">Isabel</forename><surname>Azevedo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anamaria</forename><forename type="middle">Falcão</forename><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ricardo</forename><forename type="middle">Braz</forename><surname>Nogueira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Flávio</forename><forename type="middle">Esmeraldo</forename><surname>Rolim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerly</forename><forename type="middle">Ac</forename><surname>Brito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Deysi</forename><forename type="middle">Viviana T</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberto</forename><forename type="middle">Cp</forename><surname>Lima-Júnior</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ronaldo</forename><surname>De Albuquerque Ribeiro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mariana</forename><forename type="middle">Lima</forename><surname>Vale</surname></persName>
		</author>
		<idno type="DOI">10.1186/1744-8069-9-53</idno>
		<idno type="PMID">24152430</idno>
		<idno type="PMCID">PMC3835704</idno>
		<ptr target="http://dx.doi.org/10.1186/1744-8069-9-53" />
	</analytic>
	<monogr>
		<title level="j">Molecular Pain</title>
		<title level="j" type="abbrev">Mol Pain</title>
		<idno type="ISSN">1744-8069</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">1744-8069-9-53</biblScope>
			<date type="published" when="2013-01" />
			<publisher>SAGE Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Oxaliplatininduced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">L</forename><surname>Di Cesare</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Zanardelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Failli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Ghelardini</surname></persName>
		</author>
		<idno type="PMID">22325298</idno>
	</analytic>
	<monogr>
		<title level="j">J Pain</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="276" to="84" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Oxaliplatin-Induced Neuropathy: Oxidative Stress as Pathological Mechanism. Protective Effect of Silibinin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lorenzo</forename><surname>Di Cesare Mannelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matteo</forename><surname>Zanardelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paola</forename><surname>Failli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carla</forename><surname>Ghelardini</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jpain.2011.11.009</idno>
		<idno type="PMID">22325298</idno>
		<ptr type="open-access" target="https://flore.unifi.it/bitstream/2158/727926/1/DiCesareMannelli2012.pdf" />
		<ptr target="http://dx.doi.org/10.1016/j.jpain.2011.11.009" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Pain</title>
		<title level="j" type="abbrev">The Journal of Pain</title>
		<idno type="ISSN">1526-5900</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="276" to="284" />
			<date type="published" when="2012-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">The effects of Goshajinkigan, a herbal medicine, on subjective symptoms and vibratory threshold in patients with diabetic neuropathy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masato</forename><surname>Tawata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Akihiro</forename><surname>Kurihara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kiyoaki</forename><surname>Nitta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eiichi</forename><surname>Iwase</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naoya</forename><surname>Gan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toshimasa</forename><surname>Onaya</surname></persName>
		</author>
		<idno type="DOI">10.1016/0168-8227(94)90149-x</idno>
		<idno type="PMID">7705193</idno>
		<idno type="PII">0168-8227(94)90149-X</idno>
		<idno type="ark">ark:/67375/6H6-9XC0JGQN-7</idno>
		<idno type="istexId">87CAB3B82C8459EF8B00EC42D7825AB09D7DBBB9</idno>
		<ptr target="http://dx.doi.org/10.1016/0168-8227(94" />
	</analytic>
	<monogr>
		<title level="j">Diabetes Research and Clinical Practice</title>
		<title level="j" type="abbrev">Diabetes Research and Clinical Practice</title>
		<idno type="ISSN">0168-8227</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="121" to="128" />
			<date type="published" when="1994-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Antinociceptive Mechanism of Gosha-jinki-gan in Streptozotocin-Induced Diabetic Animals: Role of Nitric Oxide in the Periphery.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasuyuki</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuhiro</forename><surname>Goto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Atsushi</forename><surname>Ishige</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasuhiro</forename><surname>Komatsu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Junzo</forename><surname>Kamei</surname></persName>
		</author>
		<idno type="DOI">10.1254/jjp.79.387</idno>
		<idno type="PMID">10230868</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/jjp/79/3/79_3_387/_pdf" />
		<ptr target="http://dx.doi.org/10.1254/jjp.79.387" />
	</analytic>
	<monogr>
		<title level="j">The Japanese Journal of Pharmacology</title>
		<title level="j" type="abbrev">Jpn.J.Pharmacol</title>
		<idno type="ISSN">0021-5198</idno>
		<idno type="ISSNe">1347-3506</idno>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="387" to="391" />
			<date type="published" when="1999" />
			<publisher>Japanese Pharmacological Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toru</forename><surname>Kono</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Taishi</forename><surname>Hata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Satoshi</forename><surname>Morita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshinori</forename><surname>Munemoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takanori</forename><surname>Matsui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroshi</forename><surname>Kojima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroyoshi</forename><surname>Takemoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mutsumi</forename><surname>Fukunaga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naoki</forename><surname>Nagata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mitsuo</forename><surname>Shimada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Junichi</forename><surname>Sakamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hideyuki</forename><surname>Mishima</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00280-013-2306-7</idno>
		<idno type="PMID">24121454</idno>
		<idno type="PMCID">PMC3834178</idno>
		<idno type="ark">ark:/67375/VQC-G5PGGQ15-N</idno>
		<idno type="istexId">91030AD743D7F25A4B8C61FE607245A695E84536</idno>
		<ptr type="open-access" target="https://link.springer.com/content/pdf/10.1007%2Fs00280-013-2306-7.pdf" />
		<ptr target="http://dx.doi.org/10.1007/s00280-013-2306-7" />
	</analytic>
	<monogr>
		<title level="j">Cancer Chemotherapy and Pharmacology</title>
		<title level="j" type="abbrev">Cancer Chemother Pharmacol</title>
		<idno type="ISSN">0344-5704</idno>
		<idno type="ISSNe">1432-0843</idno>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1283" to="1290" />
			<date type="published" when="2013-10-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naohisa</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toyoshi</forename><surname>Hosokawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Ishikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nobuaki</forename><surname>Yagi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Satoshi</forename><surname>Kokura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuji</forename><surname>Naito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masayoshi</forename><surname>Nakanishi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yukihito</forename><surname>Kokuba</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eigo</forename><surname>Otsuji</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Haruo</forename><surname>Kuroboshi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masafumi</forename><surname>Taniwaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsuya</forename><surname>Taguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hajime</forename><surname>Hosoi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Terukazu</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tsuneharu</forename><surname>Miki</surname></persName>
		</author>
		<idno type="DOI">10.1155/2013/139740</idno>
		<idno type="PMID">24307899</idno>
		<idno type="PMCID">PMC3838827</idno>
		<ptr type="open-access" target="http://downloads.hindawi.com/journals/jo/2013/139740.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Oncology</title>
		<title level="j" type="abbrev">Journal of Oncology</title>
		<idno type="ISSN">1687-8450</idno>
		<idno type="ISSNe">1687-8469</idno>
		<imprint>
			<biblScope unit="volume">2013</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2013" />
			<publisher>Hindawi Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naohisa</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toyoshi</forename><surname>Hosokawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Ishikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nobuaki</forename><surname>Yagi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Satoshi</forename><surname>Kokura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuji</forename><surname>Naito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masayoshi</forename><surname>Nakanishi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yukihito</forename><surname>Kokuba</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eigo</forename><surname>Otsuji</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Haruo</forename><surname>Kuroboshi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masafumi</forename><surname>Taniwaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsuya</forename><surname>Taguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hajime</forename><surname>Hosoi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Terukazu</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tsuneharu</forename><surname>Miki</surname></persName>
		</author>
		<idno type="DOI">10.1155/2013/139740</idno>
		<idno type="PMID">24307899</idno>
		<idno type="PMCID">PMC3838827</idno>
		<ptr type="open-access" target="http://downloads.hindawi.com/journals/jo/2013/139740.pdf" />
		<ptr target="http://dx.doi.org/10.1155/2013/139740" />
	</analytic>
	<monogr>
		<title level="j">Journal of Oncology</title>
		<title level="j" type="abbrev">Journal of Oncology</title>
		<idno type="ISSN">1687-8450</idno>
		<idno type="ISSNe">1687-8469</idno>
		<imprint>
			<biblScope unit="volume">2013</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2013" />
			<publisher>Hindawi Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Soichiro</forename><surname>Ushio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nobuaki</forename><surname>Egashira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hikaru</forename><surname>Sada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takehiro</forename><surname>Kawashiri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masafumi</forename><surname>Shirahama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ken</forename><surname>Masuguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ryozo</forename><surname>Oishi</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejca.2011.08.009</idno>
		<idno type="PMID">21907570</idno>
		<ptr target="http://dx.doi.org/10.1016/j.ejca.2011.08.009" />
	</analytic>
	<monogr>
		<title level="j">European Journal of Cancer</title>
		<title level="j" type="abbrev">European Journal of Cancer</title>
		<idno type="ISSN">0959-8049</idno>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1407" to="1413" />
			<date type="published" when="2012-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toru</forename><surname>Kono</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasuyuki</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keita</forename><surname>Mizuno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chika</forename><surname>Miyagi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuji</forename><surname>Omiya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hitomi</forename><surname>Sekine</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasuharu</forename><surname>Mizuhara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kanako</forename><surname>Miyano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshio</forename><surname>Kase</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasuhito</forename><surname>Uezono</surname></persName>
		</author>
		<idno type="DOI">10.1038/srep16078</idno>
		<idno type="PMID">26542342</idno>
		<idno type="PMCID">PMC4635352</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/srep16078.pdf" />
		<ptr target="http://dx.doi.org/10.1038/srep16078" />
	</analytic>
	<monogr>
		<title level="j">Scientific Reports</title>
		<title level="j" type="abbrev">Sci Rep</title>
		<idno type="ISSNe">2045-2322</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2015-11-06" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Goshajinkigan, a Traditional Japanese Medicine, Prevents Oxaliplatin-Induced Acute Peripheral Neuropathy by Suppressing Functional Alteration of TRP Channels in Rat</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keita</forename><surname>Mizuno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toru</forename><surname>Kono</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasuyuki</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chika</forename><surname>Miyagi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuji</forename><surname>Omiya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kanako</forename><surname>Miyano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshio</forename><surname>Kase</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasuhito</forename><surname>Uezono</surname></persName>
		</author>
		<idno type="DOI">10.1254/jphs.13244fp</idno>
		<idno type="PMID">24784702</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/jphs/125/1/125_13244FP/_pdf" />
		<ptr target="http://dx.doi.org/10.1254/jphs.13244FP" />
	</analytic>
	<monogr>
		<title level="j">Journal of Pharmacological Sciences</title>
		<title level="j" type="abbrev">J Pharmacol Sci</title>
		<idno type="ISSN">1347-8613</idno>
		<idno type="ISSNe">1347-8648</idno>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="91" to="98" />
			<date type="published" when="2014" />
			<publisher>Japanese Pharmacological Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">The Analgesic Mechanism of Processed Aconiti Tuber: The Involvement of Descending Inhibitory System</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomoko</forename><surname>Isono</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tsutomu</forename><surname>Oyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Akitoshi</forename><surname>Asami</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasuyuki</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuki</forename><surname>Hayakawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshiki</forename><surname>Ikeda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masamichi</forename><surname>Noguchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuji</forename><surname>Omiya</surname></persName>
		</author>
		<idno type="DOI">10.1142/s0192415x94000115</idno>
		<idno type="PMID">8030622</idno>
		<ptr target="http://dx.doi.org/10.1142/S0192415X94000115" />
	</analytic>
	<monogr>
		<title level="j">The American Journal of Chinese Medicine</title>
		<title level="j" type="abbrev">Am. J. Chin. Med.</title>
		<idno type="ISSN">0192-415X</idno>
		<idno type="ISSNe">1793-6853</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">01</biblScope>
			<biblScope unit="page" from="83" to="94" />
			<date type="published" when="1994-01" />
			<publisher>World Scientific Pub Co Pte Lt</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">The Astrocyte-Targeted Therapy by Bushi for the Neuropathic Pain in Mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keisuke</forename><surname>Shibata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Sugawara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kayoko</forename><surname>Fujishita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Youichi</forename><surname>Shinozaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takashi</forename><surname>Matsukawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tsutomu</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Schuichi</forename><surname>Koizumi</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0023510</idno>
		<idno type="PMID">21876755</idno>
		<idno type="PMCID">PMC3158083</idno>
		<ptr type="open-access" target="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0023510&amp;type=printable" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">e23510</biblScope>
			<date type="published" when="2011-08-18" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">The Astrocyte-Targeted Therapy by Bushi for the Neuropathic Pain in Mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keisuke</forename><surname>Shibata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Sugawara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kayoko</forename><surname>Fujishita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Youichi</forename><surname>Shinozaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takashi</forename><surname>Matsukawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tsutomu</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Schuichi</forename><surname>Koizumi</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0023510</idno>
		<idno type="PMID">21876755</idno>
		<idno type="PMCID">PMC3158083</idno>
		<ptr type="open-access" target="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0023510&amp;type=printable" />
		<ptr target="http://dx.doi.org/10.1371/journal.pone.0023510" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">e23510</biblScope>
			<date type="published" when="2011-08-18" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Efficacy of Traditional Japanese Herbal Medicines—Keishikajutsubuto (TJ-18) and Bushi-matsu (TJ-3022)—Against Postherpetic Neuralgia Aggravated by Self-Reported Cold Stimulation: A Case Series</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Miho</forename><surname>Nakanishi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Junsuke</forename><surname>Arimitsu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mitsuru</forename><surname>Kageyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shizue</forename><surname>Otsuka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takaya</forename><surname>Inoue</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shinji</forename><surname>Nishida</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hideki</forename><surname>Yoshikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuki</forename><surname>Kishida</surname></persName>
		</author>
		<idno type="DOI">10.1089/acm.2010.0745</idno>
		<idno type="PMID">22830970</idno>
		<ptr target="http://dx.doi.org/10.1089/acm.2010.0745" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Alternative and Complementary Medicine</title>
		<title level="j" type="abbrev">The Journal of Alternative and Complementary Medicine</title>
		<idno type="ISSN">1075-5535</idno>
		<idno type="ISSNe">1557-7708</idno>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="686" to="692" />
			<date type="published" when="2012-07" />
			<publisher>Mary Ann Liebert Inc</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Pharmacological Switch in Aβ-Fiber Stimulation-Induced Spinal Transmission in Mice with Partial Sciatic Nerve Injury</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Misaki</forename><surname>Matsumoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Weijiao</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lin</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroshi</forename><surname>Ueda</surname></persName>
		</author>
		<idno type="DOI">10.1186/1744-8069-4-25</idno>
		<idno type="PMID">18620588</idno>
		<idno type="PMCID">PMC2488330</idno>
		<ptr target="http://dx.doi.org/10.1186/1744-8069-4-25" />
	</analytic>
	<monogr>
		<title level="j">Molecular Pain</title>
		<title level="j" type="abbrev">Mol Pain</title>
		<idno type="ISSN">1744-8069</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">1744-8069-4-25</biblScope>
			<date type="published" when="2008-01" />
			<publisher>SAGE Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with aδ/c-fibers and colocalization with trk receptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kimiko</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsuo</forename><surname>Fukuoka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Koichi</forename><surname>Obata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroki</forename><surname>Yamanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yi</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Atsushi</forename><surname>Tokunaga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Koichi</forename><surname>Noguchi</surname></persName>
		</author>
		<idno type="DOI">10.1002/cne.20794</idno>
		<idno type="PMID">16304633</idno>
		<idno type="ark">ark:/67375/WNG-MBHMB51F-R</idno>
		<idno type="istexId">E0C06736913BF47C0F6E9E0476C388F61135C8AF</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of Comparative Neurology</title>
		<title level="j" type="abbrev">J. Comp. Neurol.</title>
		<idno type="ISSN">0021-9967</idno>
		<idno type="ISSNe">1096-9861</idno>
		<imprint>
			<biblScope unit="volume">493</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="596" to="606" />
			<date type="published" when="2005" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with aδ/c-fibers and colocalization with trk receptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kimiko</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsuo</forename><surname>Fukuoka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Koichi</forename><surname>Obata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroki</forename><surname>Yamanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yi</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Atsushi</forename><surname>Tokunaga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Koichi</forename><surname>Noguchi</surname></persName>
		</author>
		<idno type="DOI">10.1002/cne.20794</idno>
		<idno type="PMID">16304633</idno>
		<idno type="ark">ark:/67375/WNG-MBHMB51F-R</idno>
		<idno type="istexId">E0C06736913BF47C0F6E9E0476C388F61135C8AF</idno>
		<ptr target="http://dx.doi.org/10.1002/cne.20794" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Comparative Neurology</title>
		<title level="j" type="abbrev">J. Comp. Neurol.</title>
		<idno type="ISSN">0021-9967</idno>
		<idno type="ISSNe">1096-9861</idno>
		<imprint>
			<biblScope unit="volume">493</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="596" to="606" />
			<date type="published" when="2005" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Punam</forename><surname>Gauchan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tsugunobu</forename><surname>Andoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Atsushi</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasushi</forename><surname>Kuraishi</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neulet.2009.04.029</idno>
		<idno type="PMID">19375484</idno>
	</analytic>
	<monogr>
		<title level="j">Neuroscience Letters</title>
		<title level="j" type="abbrev">Neuroscience Letters</title>
		<idno type="ISSN">0304-3940</idno>
		<imprint>
			<biblScope unit="volume">458</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="93" to="95" />
			<date type="published" when="2009-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Punam</forename><surname>Gauchan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tsugunobu</forename><surname>Andoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Atsushi</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasushi</forename><surname>Kuraishi</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neulet.2009.04.029</idno>
		<idno type="PMID">19375484</idno>
		<ptr target="http://dx.doi.org/10.1016/j.neulet.2009.04.029" />
	</analytic>
	<monogr>
		<title level="j">Neuroscience Letters</title>
		<title level="j" type="abbrev">Neuroscience Letters</title>
		<idno type="ISSN">0304-3940</idno>
		<imprint>
			<biblScope unit="volume">458</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="93" to="95" />
			<date type="published" when="2009-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Acute Cold Hypersensitivity Characteristically Induced by Oxaliplatin is Caused by the Enhanced Responsiveness of TRPA1 in Mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Meng</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kouichi</forename><surname>Isami</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Saki</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hisashi</forename><surname>Shirakawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takayuki</forename><surname>Nakagawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shuji</forename><surname>Kaneko</surname></persName>
		</author>
		<idno type="DOI">10.1186/1744-8069-8-55</idno>
		<idno type="PMID">22839205</idno>
		<idno type="PMCID">PMC3495669</idno>
		<ptr type="open-access" target="https://journals.sagepub.com/doi/pdf/10.1186/1744-8069-8-55" />
		<ptr target="http://dx.doi.org/10.1186/1744-8069-8-55" />
	</analytic>
	<monogr>
		<title level="j">Molecular Pain</title>
		<title level="j" type="abbrev">Mol Pain</title>
		<idno type="ISSN">1744-8069</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">1744-8069-8-55</biblScope>
			<date type="published" when="2012-01" />
			<publisher>SAGE Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Makoto</forename><surname>Tsuda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yukari</forename><surname>Shigemoto-Mogami</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Schuichi</forename><surname>Koizumi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Akito</forename><surname>Mizokoshi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shinichi</forename><surname>Kohsaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">W</forename><surname>Salter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuhide</forename><surname>Inoue</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature01786</idno>
		<idno type="PMID">12917686</idno>
		<idno type="ark">ark:/67375/GT4-XJKBFQXW-P</idno>
		<idno type="istexId">0441B7F63BF61AE0D5D081FB2D593D94888FA3D9</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">424</biblScope>
			<biblScope unit="issue">6950</biblScope>
			<biblScope unit="page" from="778" to="783" />
			<date type="published" when="2003-08" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Makoto</forename><surname>Tsuda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yukari</forename><surname>Shigemoto-Mogami</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Schuichi</forename><surname>Koizumi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Akito</forename><surname>Mizokoshi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shinichi</forename><surname>Kohsaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">W</forename><surname>Salter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuhide</forename><surname>Inoue</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature01786</idno>
		<idno type="PMID">12917686</idno>
		<idno type="ark">ark:/67375/GT4-XJKBFQXW-P</idno>
		<idno type="istexId">0441B7F63BF61AE0D5D081FB2D593D94888FA3D9</idno>
		<ptr target="http://dx.doi.org/10.1038/nature01786" />
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">424</biblScope>
			<biblScope unit="issue">6950</biblScope>
			<biblScope unit="page" from="778" to="783" />
			<date type="published" when="2003-08" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Spinal Astrocyte Gap Junctions Contribute to Oxaliplatin-Induced Mechanical Hypersensitivity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Seo-Yeon</forename><surname>Yoon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Caleb</forename><forename type="middle">R</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Haijun</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrick</forename><forename type="middle">M</forename><surname>Dougherty</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jpain.2012.11.002</idno>
		<idno type="PMID">23374942</idno>
		<idno type="PMCID">PMC3564051</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3564051?pdf=render" />
		<ptr target="http://dx.doi.org/10.1016/j.jpain.2012.11.002" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Pain</title>
		<title level="j" type="abbrev">The Journal of Pain</title>
		<idno type="ISSN">1526-5900</idno>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="205" to="214" />
			<date type="published" when="2013-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Evidence That Spinal Astrocytes but Not Microglia Contribute to the Pathogenesis of Paclitaxel-Induced Painful Neuropathy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Haijun</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Seo-Yeon</forename><surname>Yoon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hongmei</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrick</forename><forename type="middle">M</forename><surname>Dougherty</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jpain.2011.12.002</idno>
		<idno type="PMID">22285612</idno>
		<idno type="PMCID">PMC3294066</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3294066?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Pain</title>
		<title level="j" type="abbrev">The Journal of Pain</title>
		<idno type="ISSN">1526-5900</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="293" to="303" />
			<date type="published" when="2012-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Evidence That Spinal Astrocytes but Not Microglia Contribute to the Pathogenesis of Paclitaxel-Induced Painful Neuropathy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Haijun</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Seo-Yeon</forename><surname>Yoon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hongmei</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrick</forename><forename type="middle">M</forename><surname>Dougherty</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jpain.2011.12.002</idno>
		<idno type="PMID">22285612</idno>
		<idno type="PMCID">PMC3294066</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3294066?pdf=render" />
		<ptr target="http://dx.doi.org/10.1016/j.jpain.2011.12.002" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Pain</title>
		<title level="j" type="abbrev">The Journal of Pain</title>
		<idno type="ISSN">1526-5900</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="293" to="303" />
			<date type="published" when="2012-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Spinal Astrocytic Activation Contributes to Mechanical Allodynia in a Rat Chemotherapy-Induced Neuropathic Pain Model</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xi-Tuan</forename><surname>Ji</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nian-Song</forename><surname>Qian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tao</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin-Mao</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xin-Kui</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peng</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dong-Sheng</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gang</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lei</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhou</forename><surname>Fei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dong</forename><surname>Jia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Le</forename><surname>Niu</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0060733</idno>
		<idno type="PMID">23585846</idno>
		<idno type="PMCID">PMC3621957</idno>
		<ptr type="open-access" target="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0060733&amp;type=printable" />
		<ptr target="http://dx.doi.org/10.1371/journal.pone.0060733" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">e60733</biblScope>
			<date type="published" when="2013-04-09" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Aconiti tuber (Bushi) improves microcirculatory disturbances induced by endotoxin in rats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hangjun</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshihiro</forename><surname>Sugiura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yukio</forename><surname>Goto</surname></persName>
		</author>
		<idno type="DOI">10.1002/1099-1573(200011)14:7&lt;505::aid-ptr648&gt;3.0.co;2-s</idno>
		<idno type="PMID">11054839</idno>
		<idno type="ark">ark:/67375/WNG-L66P0K3X-W</idno>
		<idno type="istexId">302057F75F9B563194AAD9DC0B7FD85A9E63F510</idno>
		<ptr target="http://dx.doi.org/10.1002/1099-1573" />
	</analytic>
	<monogr>
		<title level="j">Phytotherapy Research</title>
		<title level="j" type="abbrev">Phytother. Res.</title>
		<idno type="ISSN">0951-418X</idno>
		<idno type="ISSNe">1099-1573</idno>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="505" to="509" />
			<date type="published" when="2000" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note>7%3c505::AID-PTR648%3e3.0.CO;2-S</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Processed Aconite Root Prevents Cold-Stress-Induced Hypothermia and Immuno-Suppression in Mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toshiaki</forename><surname>Makino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Keita</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hajime</forename><surname>Mizukami</surname></persName>
		</author>
		<idno type="DOI">10.1248/bpb.32.1741</idno>
		<idno type="PMID">19801837</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/bpb/32/10/32_10_1741/_pdf" />
		<ptr target="http://dx.doi.org/10.1248/bpb.32.1741" />
	</analytic>
	<monogr>
		<title level="j">Biological &amp; Pharmaceutical Bulletin</title>
		<title level="j" type="abbrev">Biol. Pharm. Bull.</title>
		<idno type="ISSN">0918-6158</idno>
		<idno type="ISSNe">1347-5215</idno>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1741" to="1748" />
			<date type="published" when="2009" />
			<publisher>Pharmaceutical Society of Japan</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Aconiti tuber increases plasma nitrite and nitrate levels in humans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuo</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eiji</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toshio</forename><surname>Nakaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shigeru</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shigenobu</forename><surname>Kanba</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jep.2004.09.028</idno>
		<idno type="PMID">15588666</idno>
		<ptr target="http://dx.doi.org/10.1016/j.jep.2004.09.028" />
	</analytic>
	<monogr>
		<title level="j">Journal of Ethnopharmacology</title>
		<title level="j" type="abbrev">Journal of Ethnopharmacology</title>
		<idno type="ISSN">0378-8741</idno>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="165" to="169" />
			<date type="published" when="2005-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
